Manuscripts

Search by keyword, year, or author name.

Showing 1533 manuscripts.

Trimetrexate-leucovorin dosage evaluation study for treatment of pneumocystis carinii pneumonia

Fred Richard Sattler, Carmen Joseph Allegra, Thomas D. Verdegem, Bisher Akil, Carmelita U. Tuazon, Claire Hughlett, Debra M. Ogata-Arakaki, Judith Feinberg, James Shelhamer, H. Clifford Lane, Roger Davis, C. Thomas Boylen, John M. Leedom, Henry Masur. Trimetrexate-leucovorin dosage evaluation study for treatment of pneumocystis carinii pneumonia. Journal of Infectious Diseases. 1990. 161: 91-6.

Year

1990

Journal

Journal of Infectious Diseases

Activation of complement on the surface of cells infected by human immunodeficiency virus

Greg Spear, Alan Landay, Brenda L. Sullivan, B. Dittel, T. F. Lint. Activation of complement on the surface of cells infected by human immunodeficiency virus. Journal of Immunology. 1990. 144: 1490-6.

Year

1990

Journal

Journal of Immunology

Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal

Jashvant D. Unadkat, Ann C. Collier, Dana Cummings, Kent Opheim, Lawrence Corey. Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal. AIDS. 1990. 4: 229-32.

Year

1990

Journal

AIDS

Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter

John G. Bartlett, Thomas C. Merigan, Paul Volberding, Newton E. Hyslop, Stephen W. Lagakos, Douglas D. Richman, Matthew A. Koch, Fred T. Valentine, Carla Pettinelli, Lawrence Corey, Maureen Myers, David K. Booth, Henry H. Balfour, Richard C. Reichman, John Alexander Bartlett, Martin S. Hirsch, Robert L. Murphy, W. David Hardy, Ruy Soeiro, Margaret A. Fischl. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. New England Journal of Medicine. 1990. 322: 941-9.

Year

1990

Journal

New England Journal of Medicine

Management of cytomegalovirus disease with antiviral drugs

Henry H. Balfour. Management of cytomegalovirus disease with antiviral drugs. Reviews of Infectious Diseases. 1990. 12: S849-60.

Year

1990

Journal

Reviews of Infectious Diseases

Interleukin-2 in the treatment of HIV disease

David H. Schwartz, Thomas C. Merigan. Interleukin-2 in the treatment of HIV disease. Biotherapy. 1990. 2: 119-36.

Year

1990

Journal

Biotherapy

Adjusting for early treatment termination in comparative clinical trials

Stephen W. Lagakos, Lony C.L. Lim, J. Robins. Adjusting for early treatment termination in comparative clinical trials. Statistics In Medicine. 1990. 9: 1417-24.

Year

1990

Journal

Statistics In Medicine

Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis

Greg Spear, Brenda L. Sullivan, Alan Landay, T. F. Lint. Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis. Journal of Virology. 1990. 64: 5869-73.

Year

1990

Journal

Journal of Virology

A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients

Gildon Beall, Sally Kruger, F. Morales, D. Imagawa, J. A. Goldsmith, D. Fisher, James Paul Steinberg, John P. Phair, S. Whaling, J. Bitran. A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients. AIDS. 1990. 4: 679-81.

Year

1990

Journal

AIDS

A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group

Richard B. Roberts, F. Blaine Hollinger, Wade P. Parks, Suraiya Rasheed, J. Laurence, Peter Heseltine, R. W. Makuch, J. A. Lubina, Kristine M.C. Johnson. A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group. AIDS. 1990. 4: 67-72.

Year

1990

Journal

AIDS